Stephen L Lemieux, Chief Financial Officer & Secretary at Cipher Pharmaceuticals, holds 82.50K shares in Neupath Health Inc. (Ticker: TSE:NPTH), holds 19.77K shares in Cipher Pharmaceuticals (Ticker: CPHRF), holds 20.99K shares in Nuvo Pharmaceuticals (Ticker: TSE:MRV). Most recently, Stephen L Lemieux Bought ― shares of Neupath Health Inc. on Sep 07, 2020 for an estimated value of 56.25K.
What is the percentage of profitable transactions made by Stephen L Lemieux?
The percentage of profitable transactions made by Stephen L Lemieux is 67%.
What is the average return per transaction made by Stephen L Lemieux?
The average return per transaction made by Stephen L Lemieux is 47.50%.
What stocks does Stephen L Lemieux hold?
Stephen L Lemieux holds: CPHRF, TSE:MRV, TSE:NPTH, EDSA stocks.
What was Stephen L Lemieux’s latest transaction?
Stephen L Lemieux latest transaction was an Informative Buy of C$56.25K.
What was Stephen L Lemieux's most profitable transaction?
Stephen L Lemieux’s most profitable transaction was an Informative Buy of TSE:MRV stock on April 3, 2014. The return on the trade was 159.20%.
What is Stephen L Lemieux's role in Cipher Pharmaceuticals?
Stephen L Lemieux's role in Cipher Pharmaceuticals is Chief Financial Officer & Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.